FOXP3 and metabolic dysfunction-associated steatohepatitis: The IL-17A+/Foxp3+ cell ratio profile showed a sustained increment from "not NASH" to "NASH" which is clearly evident in adults (Supplementary Fig. 2 PANEL 2).